NIP-003

N/A

Report date: 2022/12/19 11:07:52
NME

Base Information

Drug NameNIP-003
Drug Alias NameNIP003NIP-003CRB4101CRB-4101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor XIa inhibitors
TargetsCoagulation factor XI
Therapy Area/IndicationsVenous ThrombosisVenous ThromboembolismThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNational Institutes Of Pharmaceutical Research And Development Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChina Resources Biopharmaceutical Co LtdNational Institutes Of Pharmaceutical Research And Development Co Ltd
Inactive CompaniesN/A
Active IndicationsVenous ThrombosisVenous ThromboembolismThromboembolism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A